CLINICAL_TRIALS
trial_result
· 2014-07-03
Clinical Trial Update: Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
Summary
Phase 3 trial evaluating Desoximetasone spray 0.25% for moderate to severe plaque psoriasis; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2014-07-03